Cargando…

Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report

BACKGROUND: Checkpoint-Inhibition has revolutionized the treatment for several entities such as melanoma and renal cell carcinoma. The first encouraging experience in ovarian cancer was reported for nivolumab, a fully humanized anti-programmed death-1 antibody. Pseudoprogression is a new phenomenon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passler, Mona, Taube, Eliane T, Sehouli, Jalid, Pietzner, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682498/ https://www.ncbi.nlm.nih.gov/pubmed/31396474 http://dx.doi.org/10.5306/wjco.v10.i7.247

Ejemplares similares

Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
por: Pietzner, Klaus, et al.
Publicado: (2018)

A rare case of ovarian cancer in pregnancy complicated by pulmonary embolus and myocardial infarction: management dilemmas
por: Nasser, Sara, et al.
Publicado: (2014)

In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging
por: Grzeski, Marta, et al.
Publicado: (2022)

Pseudo-Progression of Melanoma Treated with Nivolumab/Ipilimumab: A Case Report
por: Velazquez, Adan Martin Cuevas, et al.
Publicado: (2023)

Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis
por: Cherif, Soumia, et al.
Publicado: (2021)

Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?
por: Velho, Renata Voltolini, et al.
Publicado: (2021)

Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery(∗): A Prospective Substudy of a Randomized Controlled Trial
por: Hunsicker, Oliver, et al.
Publicado: (2015)

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
por: Nasser, Sara, et al.
Publicado: (2022)

Pseudo progression in heterogeneity of right-sided metastatic colon carcinoma during nivolumab therapy: A case report
por: Wang, Jing, et al.
Publicado: (2019)

Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature
por: Li, Hui, et al.
Publicado: (2020)

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
por: Woopen, Hannah, et al.
Publicado: (2014)

Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
por: Fotopoulou, Christina, et al.
Publicado: (2012)

Pericardial effusion under nivolumab: case-reports and review of the literature
por: Anastasia, Saade, et al.
Publicado: (2019)

Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report
por: Frumkin, David, et al.
Publicado: (2019)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases
por: Biskup, Karina, et al.
Publicado: (2014)

Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer—An Analysis of the NOGGO/JAGO
por: Heublein, Sabine, et al.
Publicado: (2023)

Sialic Acid Linkage Analysis Refines the Diagnosis of Ovarian Cancer
por: Dědová, Tereza, et al.
Publicado: (2019)

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
por: Kulbe, Hagen, et al.
Publicado: (2020)

Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment
por: Hoffmann, Karen, et al.
Publicado: (2020)

Incomplete pseudo-Meigs’ syndrome caused by endometrial ovarian cyst: A case report
por: Tsukao, Hitokazu, et al.
Publicado: (2021)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Nivolumab: Various toxicities: case report
Publicado: (2022)

SCHIZOPHRENIC PSEUDO PSEUDO DEMENTIA - A CASE REPORT
por: Khanna, Sumant, et al.
Publicado: (1988)

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
por: Ruscito, Ilary, et al.
Publicado: (2018)

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Ihlow, Jana, et al.
Publicado: (2022)

Nivolumab for malignant transformation of ovarian mature cystic teratoma
por: Yoshimura, Kayoko, et al.
Publicado: (2022)

Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance
por: Lorusso, Domenica, et al.
Publicado: (2020)

Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
por: Guo, Fang, et al.
Publicado: (2022)

Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy
por: Arsenic, Ruza, et al.
Publicado: (2015)

Ovarian dysgerminoma with pseudo-Meigs syndrome: A case report
por: Li, Xuebo, et al.
Publicado: (2021)

Nivolumab, a Double-Edged Sword: A Case Report of Nivolumab-Induced Myasthenia Gravis
por: Tahir, Nayha, et al.
Publicado: (2021)

Chondroitin Sulfate Disaccharides, a Serum Marker for Primary Serous Epithelial Ovarian Cancer
por: Biskup, Karina, et al.
Publicado: (2021)

Ipilimumab/nivolumab: Diffuse pneumonitis: case report
Publicado: (2020)

Nivolumab: Acute eosinophilic pneumonia: case report
Publicado: (2022)

Nivolumab: Immune-related meningoencephalitis: case report
Publicado: (2021)

Case Report: Nivolumab-Induced Autoimmune Pancreatitis
por: Goyal, Preeya, et al.
Publicado: (2021)

Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HR-QoL) in Patients with Ovarian Cancer: What Is Different Compared to Healthy Women?
por: Inci, Melisa Guelhan, et al.
Publicado: (2021)

Pseudo-Bartter syndrome in an infant without obvious underlying conditions: A case report
por: Toyoda, Junya, et al.
Publicado: (2023)

A case of pseudo-pseudo Meigs’ syndrome
por: Ahmed, Omnya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j06p13ko25o4oqihdeeb8nqdrg